Publication Cover
Xenobiotica
the fate of foreign compounds in biological systems
Volume 48, 2018 - Issue 10
198
Views
9
CrossRef citations to date
0
Altmetric
Xenobiotic Transporters

MicroRNA-655-3p regulates Echinacea purpurea mediated activation of ABCG2

, , , &
Pages 1050-1058 | Received 23 Aug 2017, Accepted 06 Oct 2017, Published online: 02 Nov 2017

References

  • Abdul MIM, Jiang X, Williams KM, et al. (2010). Pharmacokinetic and pharmacodynamic interactions of Echinacea and policosanol with warfarin in healthy subjects. Br J Clin Pharmacol 69:508–15
  • Antiretroviral Therapy Cohort Collaboration. (2017). Survival of HIV-positive patients starting antiretroviral therapy between 1996 and 2013: a collaborative analysis of cohort studies. Lancet HIV 4:e349–56
  • Awortwe C, Manda VK, Avonto C, et al. (2015). Echinacea purpurea up-regulates CYP1A2, CYP3A4 and MDR1 gene expression by activation of pregnane X receptor pathway. Xenobiotica 45:218–29
  • Bakhsheshian J, Hall MD, Robey RW, et al. (2013). Overlapping substrate and inhibitor specificity of human and murine ABCG2. Drug Metab Dispos 41:1805–12
  • Barnes J, Anderson LA, Gibbons S, Phillipson JD. (2005). Echinacea species (Echinacea angustifolia (DC.) Hell., Echinacea pallida (Nutt.) Nutt., Echinacea purpurea (L.) Moench): a review of their chemistry, pharmacology and clinical properties. J Pharm Pharmacol 57:929–54
  • Benson EA, Eadon MT, Desta Z, et al. (2016). Rifampin regulation of drug transporters gene expression and the association of MicroRNAs in human hepatocytes. Front Pharmacol 7:111
  • Bossaer JB, Odle BL. (2012). Probable etoposide interaction with Echinacea. J Diet Suppl 9:90–5
  • Bruckmueller H, Martin P, Kähler M, et al. (2017). Clinically relevant multidrug transporters are regulated by microRNAs along the human intestine. Mol Pharm 14:2245–53
  • Cheadle C, Vawter MP, Freed WJ, Becker KG. (2003). Analysis of microarray data using Z score transformation. J Mol Diagn 5:73–81
  • Chen Y, Tang Y, Guo C, et al. (2012). Nuclear receptors in the multidrug resistance through the regulation of drug-metabolizing enzymes and drug transporters. Biochem Pharmacol 83:1112–26
  • Clauson KA, Santamarina ML, Rutledge JC. (2008). Clinically relevant safety issues associated with St. John’s wort product labels. BMC Complement Altern Med 8:42
  • Cloonan N. (2015). Re-thinking miRNA–mRNA interactions: intertwining issues confound target discovery. Bioessays 37:379–88
  • Dweep H, Gretz N. (2015). miRWalk2.0: a comprehensive atlas of microRNA-target interactions. Nat Methods 12:697
  • Fujino T, Yokosuka A, Higurashi H, et al. (2017). AU-1 from Agavaceae plants causes transient increase in p21/Cip1 expression in renal adenocarcinoma ACHN cells in an miR-34-dependent manner. J Nat Med 71:36–43
  • Haenisch S, Laechelt S, Bruckmueller H, et al. (2011). Down-regulation of ATP-binding cassette C2 protein expression in HepG2 cells after rifampicin treatment is mediated by microRNA-379. Mol Pharmacol 80:314–20
  • Haenisch S, Werk AN, Cascorbi I. (2014). MicroRNAs and their relevance to ABC transporters. Br J Clin Pharmacol 77:587–96
  • Haenisch S, Zhao Y, Chhibber A, et al. (2015). SOX11 identified by target gene evaluation of miRNAs differentially expressed in focal and non-focal brain tissue of therapy-resistant epilepsy patients. Neurobiol Dis 77:127–40
  • Hermann R, von Richter O. (2012). Clinical evidence of herbal drugs as perpetrators of pharmacokinetic drug interactions. Planta Med 78:1458–77
  • Horsey AJ, Cox MH, Sarwat S, Kerr ID. (2016). The multidrug transporter ABCG2: still more questions than answers. Biochem Soc Trans 44:824–30
  • Howard DH, Chernew ME, Abdelgawad T, et al. (2016). New anticancer drugs associated with large increases in costs and life expectancy. Health Aff (Millwood) 35:1581–7
  • Hudson JB. (2012). Applications of the phytomedicine Echinacea purpurea (Purple Coneflower) in infectious diseases. J Biomed Biotechnol 2012:769896
  • Ikemura K, Iwamoto T, Okuda M. (2014). MicroRNAs as regulators of drug transporters, drug-metabolizing enzymes, and tight junctions: implication for intestinal barrier function. Pharmacol Ther 143:217–24
  • Ingelman-Sundberg M, Zhong XB, Hankinson O, et al. (2013). Potential role of epigenetic mechanisms in the regulation of drug metabolism and transport. Drug Metab Dispos 41:1725–31
  • Izzo AA, Hoon-Kim S, Radhakrishnan R, Williamson EM. (2016). A critical approach to evaluating clinical efficacy, adverse events and drug interactions of herbal remedies. Phytother Res 30:691–700
  • Jawad M, Schoop R, Suter A, et al. (2012). Safety and efficacy profile of Echinacea purpurea to prevent common cold episodes: a randomized, double-blind, placebo-controlled trial. Evid Based Complement Alternat Med 2012:841315
  • Katz IT, Maughan-Brown B. (2017). Improved life expectancy of people living with HIV: who is left behind? Lancet HIV 4:e324–6
  • Li H, Wang H. (2010). Activation of xenobiotic receptors: driving into the nucleus. Expert Opin Drug Metab Toxicol 6:409–26
  • Li Y, Wang Y, Wu Y, et al. (2017). Echinacea purpurea extracts promote murine dendritic cell maturation by activation of JNK, p38 MAPK and NF-κB pathways. Dev Comp Immunol 73:21–6
  • Li Y, Zhao L, Li N, et al. (2017). miR-9 regulates the multidrug resistance of chronic myelogenous leukemia by targeting ABCB1. Oncol Rep 37:2193–200
  • Livak KJ, Schmittgen TD. (2001). Analysis of relative gene expression data using real-time quantitative PCR and the 2(–Delta Delta C(T)) Method. Methods 25:402–8
  • Milenkovic D, Deval C, Gouranton E, et al. (2012). Modulation of miRNA expression by dietary polyphenols in apoE deficient mice: a new mechanism of the action of polyphenols. PLoS One 7:e29837
  • Moltó J, Valle M, Miranda C, et al. (2012). Herb–drug interaction between Echinacea purpurea and etravirine in HIV-infected patients. Antimicrob Agents Chemother 56:5328–31
  • Mottino AD, Catania VA. (2008). Hepatic drug transporters and nuclear receptors: regulation by therapeutic agents. World J Gastroenterol 14:7068–74
  • Mousa HAL. (2017). Prevention and treatment of influenza, influenza-like illness, and common cold by herbal, complementary, and natural therapies. J Evid Based Complementary Altern Med 22:166–74
  • Mrozikiewicz PM, Bogacz A, Karasiewicz M, et al. (2010). The effect of standardized Echinacea purpurea extract on rat cytochrome P450 expression level. Phytomedicine 17:830–3
  • Müller J, Keiser M, Drozdzik M, Oswald S. (2017). Expression, regulation and function of intestinal drug transporters: an update. J Biol Chem 398:175–92
  • Murakami Y, Tanaka T, Murakami H, et al. (2006). Pharmacokinetic modelling of the interaction between St John's wort and ciclosporin A. Br J Clin Pharmacol 61:671–6
  • Oliveto S, Mancino M, Manfrini N, Biffo S. (2017). Role of microRNAs in translation regulation and cancer. World J Biol Chem 8:45–56
  • Ondieki G, Nyagblordzro M, Kikete S, et al. (2017). Cytochrome P450 and P-glycoprotein-mediated interactions involving African herbs indicated for common noncommunicable diseases. Evid Based Complement Alternat Med 2017:2582463
  • Oshima G, Guo N, He C, et al. (2017). In vivo delivery and therapeutic effects of a microRNA on colorectal liver metastases. Mol Ther 25:1588–95
  • Parker LP, Taylor DD, Kesterson J, et al. (2009). Modulation of microRNA associated with ovarian cancer cells by genistein. Eur J Gynaecol Oncol 30:616–21
  • Patel RD, Hollingshead BD, Omiecinski CJ, Perdew GH. (2007). Aryl-hydrocarbon receptor activation regulates constitutive androstane receptor levels in murine and human liver. Hepatology 46:209–18
  • Peng L, Zhong X. (2015). Epigenetic regulation of drug metabolism and transport. Acta Pharm Sin B 5:106–12
  • Penzak SR, Robertson SM, Hunt JD, et al. (2010). Echinacea purpurea significantly induces cytochrome P450 3A activity but does not alter lopinavir-ritonavir exposure in healthy subjects. Pharmacotherapy 30:797–805
  • Rasmussen MK, Daujat-Chavanieu M, Gerbal-Chaloin S. (2017). Activation of the aryl hydrocarbon receptor decreases rifampicin-induced CYP3A4 expression in primary human hepatocytes and HepaRG. Toxicol Lett 277:1–8
  • Sethi S, Li Y, Sarkar FH. (2013). Regulating miRNA by natural agents as a new strategy for cancer treatment. Curr Drug Targets 14:1167–74
  • Sharma D, Turkistani AA, Chang W, et al. (2017). Negative regulation of human pregnane X receptor by microRNA-18a-5p: evidence for suppression of microRNA-18a-5p expression by rifampin and rilpivirine. Mol Pharmacol 92:48–56
  • Tan KW, Cooney J, Jensen D, et al. (2014). Hop-derived prenylflavonoids are substrates and inhibitors of the efflux transporter breast cancer resistance protein (BCRP/ABCG2). Mol Nutr Food Res 58:2099–110
  • Thakur VS, Deb G, Babcook MA, Gupta S. (2014). Plant phytochemicals as epigenetic modulators: role in cancer chemoprevention. AAPS J 16:151–63
  • Tsai YL, Chiu CC, Yi-Fu Chen J, et al. (2012). Cytotoxic effects of Echinacea purpurea flower extracts and cichoric acid on human colon cancer cells through induction of apoptosis. J Ethnopharmacol 143:914–9
  • Xiao CQ, Chen R, Lin J, et al. (2012). Effect of genistein on the activities of cytochrome P450 3A and P-glycoprotein in Chinese healthy participants. Xenobiotica 42:173–8
  • Yan L, Liu J, Zhao Y, et al. (2017). Suppression of miR-628-3p and miR-641 is involved in rifampin-mediated CYP3A4 induction in HepaRG cells. Pharmacogenomics 18:57–64
  • Yang Z, Wang L. (2011). Regulation of microRNA expression and function by nuclear receptor signaling. Cell Biosci 1:31
  • Yu CP, Hsieh YC, Shia CS, et al. (2016). Increased systemic exposure of methotrexate by a polyphenol-rich herb via modulation on efflux transporters multidrug resistance-associated protein 2 and breast cancer resistance protein. J Pharm Sci 105:343–9

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.